<DOC>
	<DOCNO>NCT01815541</DOCNO>
	<brief_summary>This biomedical research , prospective , mono centric , tolerance study Of administration subcutaneous teicoplanin treatment osteoarticular infection .</brief_summary>
	<brief_title>Administration Subcutaneous Teicoplanin Treatment Osteoarticular Infections : Tolerance Study</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Teicoplanin</mesh_term>
	<criteria>Patient 18 year Inpatient orthopedic surgery Achieved bone joint infection document gram + ( staphylococci golden coagulasenegative staphylococci , enterococci , streptococci ) Bacteria resistant lincosamides , quinolones rifampicin Bacteria susceptible teicoplanin ( MIC â‰¤ 4 mg / L ) Balanced patient teicoplanin administer intravenously ( 2 successive dos 30 40 mg / mL ) Patient affiliate social security Pregnant lactate woman Known hypersensitivity teicoplanin ( rash , ... ) Patients central catheter implantable chamber Patient hemodialysis Patient another participant biomedical research drug prevent drug interaction Patient minor Patient major protect ( protection court , wardship , trusteeship ) Patient admit emergency incapable consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>subcutaneous teicoplanin</keyword>
	<keyword>osteoarticular</keyword>
	<keyword>infection</keyword>
	<keyword>tolerance</keyword>
	<keyword>teicoplanin</keyword>
</DOC>